<DOC>
	<DOCNO>NCT00411073</DOCNO>
	<brief_summary>This study assess effect darapladib cardiac conduction heart compare placebo moxifloxacin . This four period crossover design period last 10 day . There 7 10 day wash period .</brief_summary>
	<brief_title>Study Of The Effects Of SB 480848 ( Darapladib ) On The Electrical Conduction Of The Heart</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Darapladib</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<criteria>Healthy Body weight great 50 kg ( 110 lb ) body mass index 19 30 Signed date write informed consent prior admission study Subject able understand comply protocol requirement , instruction protocolstated restriction cardiac abnormality history asthma severe allergic reaction history alcohol drug abuse use prescription nonprescription drug vitamins herbal supplement history cholecystectomy biliary tract disease pregnant nursing woman history allergy study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>darapladib</keyword>
	<keyword>moxifloxacin</keyword>
	<keyword>QT study</keyword>
</DOC>